Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Second Quarter 2019 Financial Results and Corporate Upd...
August 01 2019 - 8:00AM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases, today announced that the Company will
host a conference call on Thursday, August 8, 2019, at 8:00 a.m.
EDT to discuss financial results and provide a corporate update for
the quarter ended June 30, 2019. The dial-in numbers are
1-866-211-4098 for domestic callers and 1-647-689-6613 for
international callers. The conference ID number for the live call
will be 9329328. A live webcast of the conference call will also be
available on the investor relations page of the Aldeyra
Therapeutics corporate website at www.aldeyra.com.
After the live webcast, the event will remain archived on the
Aldeyra Therapeutics website for one year.
About Aldeyra Therapeutics Aldeyra Therapeutics is a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases. Aldeyra’s lead investigational drug
product candidates are first-in-class potential treatments in
development for dry eye disease, allergic conjunctivitis,
proliferative vitreoretinopathy, and Sj�gren-Larsson Syndrome. The
company is also developing other product candidates for retinal and
systemic inflammatory diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190801005066/en/
Corporate Contact: David McMullin Aldeyra Therapeutics,
Inc. Tel: 781-761-4904 ext. 218 dmcmullin@aldeyra.com Investor
Contact: Chris Brinzey Westwicke, an ICR Company Tel:
339-970-2843 Chris.brinzey@westwicke.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024